NXL

Quote

Short

News

Articles

Message Board

Nexalin Technology Inc. (NASDAQ : NXL ) News

Nexalin Technology Inc. (NASDAQ: NXL) News Releases

NXL News Releases

June 04, 2026 10:00:00 am

GlobeNewswire

Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and Insomnia

May 21, 2026 08:30:00 am

GlobeNewswire

Nexalin Technology Secures Key Neurostimulation Legislative Provision & Commends U.S. House-Passed Report Language Expanding Non-Invasive Deep Brain Neurostimulation Research at the Department of Veterans Affairs for Traumatic Brain Injury

May 19, 2026 08:30:00 am

GlobeNewswire

Nexalin Acquires AI-Integrated Digital Health Platform Behind HALO(TM) Clarity and Nexalin NeuroCare(TM) Ahead of Planned FDA Pivotal Trial

April 28, 2026 09:15:00 am

GlobeNewswire

Nexalin Announces Peer-Reviewed Publication with Neuroimaging Data in Psychotherapy and Psychosomatics Highlighting Brain-Network Effects and Clinical Improvement in Chronic Insomnia

April 22, 2026 09:35:00 am

GlobeNewswire

Nexalin Technology Advances Pivotal Clinical Trial of HALO(TM) Clarity Toward Q2 2026 Enrollment

April 15, 2026 10:00:00 am

GlobeNewswire

Nexalin Advances FDA Alzheimer's Strategy Following Landmark Leadership Meetings in the U.S. and China

April 14, 2026 08:30:00 am

GlobeNewswire

Join Nexalin's Exclusive Live Investor Webinar and Q&A Session on April 21

April 10, 2026 07:11:20 am

SeekingAlpha

NexLiving Communities reports Q4 results

April 09, 2026 07:47:00 am

GlobeNewswire

Nexalin Announces Peer-Reviewed Study Showing the Company's DIFS(TM) Technology Reduced Self-Injury and Depression Symptoms in Female Adolescents

February 24, 2026 08:07:00 am

GlobeNewswire

Nexalin Announces Pivotal HALO(TM) Clarity Trial to Support Planned De Novo FDA Submission Targeting Multi-Billion-Dollar Insomnia Market

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account